
Feb 11 (Reuters) - UK MHRA:
MHRA: IXCHIQ CHIKUNGUNYA VACCINE IS NO LONGER INDICATED FOR ADULTS OVER AGE OF 60 YEARS
MHRA: IXCHIQ VACCINE IS CONTRAINDICATED IN INDIVIDUALS WITH HYPERTENSION, CARDIOVASCULAR DISEASE, DIABETES MELLITUS, &/OR CHRONIC KIDNEY DISEASE
MHRA: COMMISSION ON HUMAN MEDICINES HAVE ADVISED THAT IXCHIQ VACCINE SHOULD BE GIVEN NO LATER THAN 30 DAYS PRIOR TO TRAVEL